Stockreport

CEL-SCI Reports Fiscal 2025 Results

Cel-Sci Corporation  (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
PDF Filed for Breakthrough Designation for Multikine in Saudi ArabiaA 212-patient Confirmatory Registration Study for Multikine in PD-L1 low newly diagnosed head and neck ca [Read more]